Works by Caminis, John


Results: 13
    1
    2
    3

    Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia trachomatis Infection: A Randomized, Double-blind, Double-Dummy, Active-Controlled, Multicenter Trial.

    Published in:
    Clinical Infectious Diseases, 2012, v. 55, n. 1, p. 82, doi. 10.1093/cid/cis291
    By:
    • Geisler, William M.;
    • Koltun, William D.;
    • Abdelsayed, Nader;
    • Burigo, John;
    • Mena, Leandro;
    • Taylor, Stephanie N.;
    • Batteiger, Byron E.;
    • Thurman, Andrea R.;
    • Hook, Edward W.;
    • Vaughn, Toby A.;
    • Annett, Miriam P.;
    • Muenzen, Ruth A.;
    • Caminis, John
    Publication type:
    Article
    4
    5
    6

    Bone circuitry and interorgan skeletal crosstalk.

    Published in:
    eLife, 2023, p. 1, doi. 10.7554/eLife.83142
    By:
    • Zaidi, Mone;
    • Se-Min Kim;
    • Mathew, Mehr;
    • Korkmaz, Funda;
    • Sultana, Farhath;
    • Miyashita, Sari;
    • Gumerova, Anisa Azatovna;
    • Frolinger, Tal;
    • Moldavski, Ofer;
    • Barak, Orly;
    • Pallapati, Anusha;
    • Rojekar, Satish;
    • Caminis, John;
    • Ginzburg, Yelena;
    • Ryu, Vitaly;
    • Davies, Terry F.;
    • Lizneva, Daria;
    • Rosen, Clifford J.;
    • Tony Yuen
    Publication type:
    Article
    7
    8
    9

    Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.

    Published in:
    Pharmacology Research & Perspectives, 2018, v. 6, n. 1, p. 1, doi. 10.1002/prp2.380
    By:
    • Hillson, Jan;
    • Mant, Tim;
    • Rosano, Molly;
    • Huntenburg, Carolyn;
    • Alai-Safar, Mehrshid;
    • Darne, Siddhesh;
    • Palmer, Donna;
    • Pavlova, Borislava G.;
    • Doralt, Jennifer;
    • Reeve, Russell;
    • Goel, Niti;
    • Weilert, Doris;
    • Rhyne, Paul W.;
    • Chance, Kamali;
    • Caminis, John;
    • Roach, James;
    • Ganguly, Tanmoy
    Publication type:
    Article
    10

    Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study.

    Published in:
    Journal of Bone & Mineral Research, 2018, v. 33, n. 8, p. 1397, doi. 10.1002/jbmr.3452
    By:
    • McClung, Michael R.;
    • Brown, Jacques P.;
    • Diez‐Perez, Adolfo;
    • Resch, Heinrich;
    • Caminis, John;
    • Meisner, Paul;
    • Bolognese, Michael A.;
    • Goemaere, Stefan;
    • Bone, Henry G.;
    • Zanchetta, Jose R.;
    • Maddox, Judy;
    • Bray, Sarah;
    • Grauer, Andreas
    Publication type:
    Article
    11
    12
    13